Literature DB >> 27538116

Chinese herbal medicine for atopic eczema: an overview of clinical evidence.

Sherman X Gu1, Anthony L Zhang1, Meaghan E Coyle1, Dacan Chen2, Charlie C Xue1,2.   

Abstract

Atopic eczema (AE), or atopic dermatitis, is a common inflammatory skin disease. As conventional medicines for moderate and severe AE patients have been reported to be associated with unwanted side effects, many patients with AE have sought other therapies. Chinese herbal medicine (CHM) is one of the most commonly used complementary therapies with a long history of being applied for the treatment of AE. Clinical evidence for CHM for AE in systematic reviews and randomised controlled trials (RCTs) published from 2013 to 2016 was reviewed. Findings from the Cochrane systematic review suggested that oral use of a CHM formulation may improve health-related quality of life (HRQoL) of children with moderate or severe AE. The benefit on improvement of AE requires further high-quality clinical studies.

Entities:  

Keywords:  Atopic eczema; Chinese herbal medicine; atopic dermatitis; randomised controlled trials; systematic review

Mesh:

Substances:

Year:  2016        PMID: 27538116     DOI: 10.1080/09546634.2016.1214673

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

1.  Corticosteroid phobia: a questionnaire study using TOPICOP score.

Authors:  Ellie Choi; Nisha Suyien Chandran; Chris Tan
Journal:  Singapore Med J       Date:  2019-09-19       Impact factor: 1.858

Review 2.  Experimental Drugs with the Potential to Treat Atopic Eczema.

Authors:  Kam Lun Ellis Hon; Vivian P Y Chan; Alexander K C Leung
Journal:  J Exp Pharmacol       Date:  2021-05-12

Review 3.  Effectiveness and Safety of Herbal Medicine for Atopic Dermatitis: An Overview of Systematic Reviews.

Authors:  Chan-Young Kwon; Boram Lee; Suran Kim; Jaesuk Lee; Minjung Park; Namkwen Kim
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-17       Impact factor: 2.629

4.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic Eczema.

Authors:  Wei Xu; Yan Li; Mei Ju; Wei Lai; Xueyan Lu; Huijuan Shi; Weimin Shi; Heng Gu; Linfeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-30       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.